The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: William John Plovanic - Canaccord Genuity Corp., Research Division - Analyst
: Can you hear me okay?
Question: William John Plovanic - Canaccord Genuity Corp., Research Division - Analyst
: So just a couple of questions. Just to start out on the AngioVac product. It's pretty strong growth year-over-year. How much of that do you think
is COVID-related versus -- or new account related? Or any color would be greatly appreciated.
Question: William John Plovanic - Canaccord Genuity Corp., Research Division - Analyst
: Okay. And then in terms of the mechanical product, just looking at the time line, so it looks like this will be a launch -- approval and launch late this
calendar year. And I'm looking at Slide 12 of the chart. And I'm just -- so that's first, just to clarify that. And then secondly, trying to understand
what's the difference between Gen 1 and Gen 2? And if you can help us out with that?
Question: William John Plovanic - Canaccord Genuity Corp., Research Division - Analyst
: Okay. And then 2 more questions. Just one clarity on the mechanical product. As you talk about control, would that be some sort of automated
aspiration associated with it? Or would it be manual?
Question: William John Plovanic - Canaccord Genuity Corp., Research Division - Analyst
: Okay. And then just last question was bigger picture volume related. I think, Steve, you mentioned you were a bit pleasantly surprised that the
amount of COVID impact in December. And just as we think about that as you think about kind of moving into your fiscal third quarter, there's 2
impacts. Our seasonality, which is typically down 1% to 3%, and then there's the COVID impact. I mean how it is -- we're through December and
into January? And it seems like it's less -- it seems -- and not to put words in your mouth, but it's more of a stable environment or from it, it's down,
whatever, it's 5% to 10% of normal volumes, but that seems to be kind of stable the last couple of months. Is that what I'm hearing? If you could
just clarify -- help clarify that for me, from a broader volume standpoint?
|
